Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 330 - 343Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Maldonado, F, Tazelaar, HD, Wang, C-W, et al. Yellow nail syndrome. Chest 2008; 134: 375.CrossRefGoogle ScholarPubMed
Myers, KA, Farquhar, DR. The rational clinical examination: does this patient have clubbing? JAMA 2001; 286: 341.CrossRefGoogle ScholarPubMed
Nguyen, J, Cotserelis, G. Diseases of the nail unit. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Borghi, I, Schianchi, T, Meschi, T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346: 77.CrossRefGoogle ScholarPubMed
Coe, FL, Parks, JH, Asplin, JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1141.CrossRefGoogle ScholarPubMed
Curhan, GC, Willett, WC, Rimm, EB, et al. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8: 1568.CrossRefGoogle ScholarPubMed
Hirvonen, T, Pietinen, P, Virtanen, M, et al. Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Am J Epidemiol 1999; 150: 187.CrossRefGoogle ScholarPubMed
Jackman, SV, Potter, SR, Regan, F, et al. Plain abdominal x-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol 2000; 164: 308.CrossRefGoogle ScholarPubMed
NIH Consensus Development Panel. Prevention and treatment of kidney stones. JAMA 1988; 260: 977.Google Scholar
Nishiura, JL, Heilberg, IP. Nephrolithiasis. In: Scientific American Medicine. Nephrology. Hamilton: Dekker Medicine. 2020.Google Scholar
Singer, A, Das, S. Cystinuria: a review of the pathophysiology and management. J Urol 1989; 142: 669.CrossRefGoogle ScholarPubMed
Wilson, DM. Clinical and laboratory evaluation of renal stone patients. Endocrinol Metab Clin North Am 1990; 19: 773.Google Scholar
Bibliography
Arieff, AI, Guisado, R, Massry, SG, et al. Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest 1976; 58: 306.CrossRefGoogle ScholarPubMed
Arieff, AI, Massry, SG, Barrientos, A, et al. Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 1973; 4: 177.CrossRefGoogle ScholarPubMed
Aronoff, GR, Bennett, WM, Berns, JS, eds. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults. 5th edition. Philadelphia: American College of Physicians. 2007.Google Scholar
Bellomo, R, Kellum, JA, Ronco, C. Defining acute renal failure: physiological principles. Intens Care Med 2004; 30: 33.Google Scholar
Berg, KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000; 34: 317.CrossRefGoogle ScholarPubMed
Caruana, RJ. Heparin free dialysis: comparative data and results in high risk patients. Kidney Int 1987; 31: 1351.CrossRefGoogle ScholarPubMed
Chandraker, A, ed. Nephrology. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Cronin, RE, Kaehny, WD, Miller, PD, et al. Renal cell carcinoma: unusual systemic manifestations. Medicine 1976; 55: 291.CrossRefGoogle ScholarPubMed
Dossetor, JB. Creatininemia versus uremia: the relative significance of blood urea nitrogen and serum creatinine in azotemia. Ann Intern Med 1966; 65: 1287.CrossRefGoogle ScholarPubMed
Fraser, CL, Arieff, AI. Nervous system complications of uremia. Ann Intern Med 1988; 109: 143.CrossRefGoogle ScholarPubMed
Hoitsma, AJ, Wetzels, JFM, Koene, RAP. Drug-induced nephrotoxicity: aetiology, clinical features and management. Drug Safety 1991; 6: 131.Google Scholar
Keshaviah, P, Shapiro, FL. A critical examination of dialysis-induced hypotension. Am J Kidney Dis 1982; 2: 290.Google Scholar
Koyner, JL. Assessment and diagnosis of renal dysfunction in the ICU. Chest 2012; 141: 1584.CrossRefGoogle ScholarPubMed
Levey, AS, Bosch, JP, Lewis, JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461.CrossRefGoogle ScholarPubMed
Li, PKT, Burdmann, EA, Mehta, RL. Acute kidney injury: global health alert. Intern Med J 2013; 43: 223.CrossRefGoogle ScholarPubMed
Massry, SG, Glassock, RJ, eds. Textbook of Nephrology. 4th edition. Baltimore: Williams & Wilkins. 2001.Google Scholar
Mathew, T. Recurrence of disease after renal transplantation. Am J Kidney Dis 1988; 12: 85.CrossRefGoogle ScholarPubMed
Morgan, DB, Dillon, S, Payne, RB. The assessment of glomerular function: creatinine clearance or plasma creatinine? Postgrad Med J 1978; 54: 302.CrossRefGoogle ScholarPubMed
Raskin, NH, Fishman, RA. Neurologic disorders in renal failure. N Engl J Med 1976; 294: 143.CrossRefGoogle ScholarPubMed
Ronco, PM, Flahault, A. Drug-induced end-stage renal disease. N Engl J Med 1994; 331: 1711.Google Scholar
Schrier, RW. An odyssey into the milieu interieur: pondering the enigmas. J Am Soc Nephrol 1992; 2: 1549.Google Scholar
Schwartz, WB, Relman, AS. Effects of electrolyte disorders on renal structure and function. N Engl J Med 1967; 276: 383 & 452.CrossRefGoogle ScholarPubMed
Sherman, RA, Eisinger, RP. The use (and misuse) of urinary sodium and chloride measurements. JAMA 1982; 247: 3121.Google Scholar
Stamm, WE, Hooton, TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329: 1328.Google Scholar
Turner, NN, Lameire, N, Goldsmith, DJ, et al. eds. Oxford Textbook of Clinical Nephrology. 4th edition. Oxford: Oxford University Press. 2015.CrossRefGoogle Scholar
Various. Issue number 6 dedicated to acute kidney injury. Intens Care Med 2017; 43: 727.Google Scholar
Bibliography
Martuza, RL, Eldridge, R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 1988; 318: 684.Google Scholar
Reynolds, RM, Browning, GG, Nawroz, I, et al. Von Recklinghausen’s neurofibromatosis: neurofibromatosis type 1. Lancet 2003; 361: 1552.CrossRefGoogle ScholarPubMed
Bibliography
Bienvenu, OJ, Neufeld, KJ, Needham, DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med 2012; 40: 2662.Google ScholarPubMed
Caroff, SN, Mann, SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77: 185.CrossRefGoogle ScholarPubMed
Guze, BH, Baxter, LR. Neuroleptic malignant syndrome. N Engl J Med 1985; 313: 163.CrossRefGoogle ScholarPubMed
Harradine, PG, Williams, SE, Doherty, SR. Neuroleptic malignant syndrome: an underdiagnosed condition. Med J Aust 2001; 174: 593.Google Scholar
Kornhuber, J, Weller, M. Neuroleptic malignant syndrome. Curr Opin Neurol Neurosurg 1994; 7: 353.CrossRefGoogle ScholarPubMed
Rosenberg, MR, Green, M. Neuroleptic malignant syndrome: review of response to therapy. Ach Intern Med 1989; 149: 1927.CrossRefGoogle ScholarPubMed
Shaw, A, Mathews, EE. Postoperative neuroleptic malignant syndrome. Anesthesiology 1995; 50: 246.Google Scholar
Bibliography
Arieff, AI, Guisado, R, Massry, SG, et al. Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest 1976; 58: 306.Google Scholar
Arieff, AI, Massry, SG, Barrientos, A, et al. Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 1973; 4: 177.Google Scholar
Bhardwaj, A, Williams, MA, Hanley, DF, eds. Critical Care of Stroke. In: New Horizons. Baltimore: Williams & Wilkins and SCCM. 1997; 5: no. 4.Google Scholar
Bolton, CF. Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations. Crit Care Med 1996; 24: 1408.CrossRefGoogle ScholarPubMed
Bolton, CF. Neuromuscular conditions in the intensive care unit. Intens Care Med 1996; 22: 841.CrossRefGoogle ScholarPubMed
Caplan, LR, Brass, LM, DeWitt, LD, et al. Transcranial Doppler ultrasound: present status. Neurology 1990; 40: 696.Google Scholar
Chang, CWJ. Neurologic complications of critical illness and transplantation. Curr Opin Crit Care 1999; 5: 112.Google Scholar
Charness, ME, Simon, RP, Greenberg, DA. Ethanol and the nervous system. N Engl J Med 1989; 321: 442.Google Scholar
Chiappa, KH, Ropper, AH. Evoked potentials in clinical medicine. N Engl J Med 1982; 306: 1140 & 1205.CrossRefGoogle ScholarPubMed
Ciavarella, D, Wuest, D, Strauss, RG, et al. Management of neurologic disorders. J Clin Apheresis 1993; 8: 242.Google Scholar
Fraser, CL, Arieff, AI. Nervous system complications of uremia. Ann Intern Med 1988; 109: 143.CrossRefGoogle ScholarPubMed
Ghaoui, R, Clarke, N, Hollingworth, P, et al. Muscle disorders: the latest investigations. Intern Med J 2013; 43: 970.Google Scholar
Hansen-Flaschen, J. Neuromuscular complications of critical illness. Pulm Perspect 1997; 14(4): 1.Google Scholar
Hughes, AJ, Biggs, BA. Parasitic worms of the central nervous system. Intern Med J 2002; 32: 541.Google Scholar
Kelly, BJ, Luce, JM. The diagnosis and management of neuromuscular diseases causing respiratory failure. Chest 1991; 99: 1485.CrossRefGoogle ScholarPubMed
Kirkman, MA, Citerio, G, Smith, M. The intensive care management of acute ischemic stroke: an overview. Intens Care Med 2014; 40: 640.Google Scholar
Klebanoff, LM, ed. Neurology. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Knochel, J. Neuromuscular manifestations of electrolyte disorders. Am J Med 1982; 72: 521.CrossRefGoogle ScholarPubMed
Lansberg, MG, O’Donnell, MJ, Khatri, P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2012; 141: S601.Google Scholar
Le Roux, P, Menon, DK, Vespa, G, et al. Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care. Intens Care Med 2014; 40: 1189.Google Scholar
Lyons, MK, Meyer, FB. Cerebrospinal fluid physiology and the management of increased intracranial pressure. Mayo Clin Proc 1990; 65: 684.CrossRefGoogle ScholarPubMed
Marton, KI, Gean, AD. The spinal tap: a new look at an old test. Ann Intern Med 1986; 104: 840.CrossRefGoogle Scholar
McMahon, SB, Kolzenburg, M, Tracey, I, et al. Wall and Melzack’s Textbook of Pain. 6th edition. Edinburgh: Elsevier. 2013.Google Scholar
Mirski, MA, Varelas, PN. Diagnosis and treatment of seizures in the adult intensive care unit. Contemporary Critical Care 2003; 1: 1.Google Scholar
Miller, DH, Raps, EC, eds. Critical Care Neurology. Woburn: Butterworth-Heinemann. 1999.Google Scholar
Moore, PM. Diagnosis and management of isolated angiitis of the central nervous system. Neurology 1989; 39: 167.Google Scholar
Polkey, MI, Moxham, J. Clinical aspects of respiratory muscle dysfunction in the critically ill. Chest 2001; 119: 926.CrossRefGoogle ScholarPubMed
Raskin, NH, Fishman, RA. Neurologic disorders in renal failure. N Engl J Med 1976; 294: 143.Google Scholar
Rosenberg, RN. Biochemical genetics of neurologic disease. N Engl J Med 1981; 305: 1181.Google Scholar
Rosenberg, RN, ed. Atlas of Clinical Neurology. 4th edition. New York: Springer. 2019.Google Scholar
Schwartzman, RJ, McLellan, TL. Reflex sympathetic dystrophy: a review. Arch Neurol 1987; 44: 555.Google Scholar
Sharshar, T, Citerio, G, Andrews, PJD, et al. Neurological examination of critically ill patients. Intens Care Med 2014; 40: 484.Google Scholar
Strange, K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992; 3: 12.Google Scholar
Suarez, JI, Bershad, EM, Rao, CPV, eds. Critical Care Neurology and Neurosurgery. 2nd edition. New York: Springer. 2020.Google Scholar
Swift, TR. Disorders of neuromuscular transmission other than myasthenia gravis. Muscle Nerve 1981; 4: 334.Google Scholar
Tonner, DR, Schlechte, JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am 1993; 77: 251.Google Scholar
Torbey, MT, ed. Neurocritical Care. 2nd edition. Cambridge: Cambridge University Press. 2019.Google Scholar
Wijdicks, EFM. Neurologic Complications of Critical Illness. 3nd edition. Oxford: Oxford University Press. 2009.CrossRefGoogle Scholar
Zweiman, B, Levinson, AI. Immunologic aspects of neurological and neuromuscular diseases. JAMA 1992; 268: 2918.Google Scholar
Bibliography
Bercker, S, Weber-Carstens, S, Deja, M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33: 711.Google Scholar
Berek, K, Margreiter, J, Willeit, J, et al. Polyneuropathies in critically ill patients: a prospective evaluation. Intens Care Med 1996; 22: 849.Google Scholar
Bleck, TP. The expanding spectrum of critical illness polyneuropathy. Crit Care Med 1996; 24: 1282.Google Scholar
Bolton, CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24: 1408.Google Scholar
Bolton, CF. Critical illness polyneuropathy and myopathy. Crit Care Med 2001; 29: 2388.Google Scholar
Bolton, CF, Gilbert, JJ, Hahn, AF, et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47: 1223.Google Scholar
Bromberg, MB, Feldman, EL, Albers, JW. Chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1992; 42: 1157.Google Scholar
Chad, DA, Lacomis, D. Critically ill patients with newly acquired weakness: the clinicopathological spectrum. Ann Neurol 1994; 35: 257.Google Scholar
Dalakas, MC, Engel, WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981; 9 (suppl.): 134.CrossRefGoogle ScholarPubMed
Davis, GA, Day, TJ. Peripheral nerve entrapment: how to diagnose and when to refer. Med J Aust 2022; 216: 126.Google Scholar
De Jonghe, B, Cook, D, Sharshar, T, et al. Acquired neuromuscular disorders in critically ill patients: a systematic review. Intens Care Med 1998; 24: 1242.Google Scholar
De Jonghe, B, Sharshar, T, Hopkinson, N, et al. Paresis following mechanical ventilation. Curr Opin Crit Care 2004; 10: 47.Google Scholar
de Letter, M-ACJ, Schmitz, PIM, Visser, LH, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001; 29: 2281.Google Scholar
Dyck, PJ, Kratz, KM, Karnes, JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817.Google Scholar
Fuller, GN, Jacobs, JM, Guiloff, RJ. Nature and incidence of peripheral neuropathy syndromes in HIV infection. J Neurol Neurosurg Psychiatry 1993; 56: 372.Google Scholar
Garnacho-Montero, J, Mandrazo-Osuna, J, Garcia-Garmendia, JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. Intens Care Med 2001; 27: 1288.Google Scholar
Hall, JB, Griffiths, RD, eds. ICU-acquired weakness: proceedings of a round table conference in Brussels, Belgium, March 2009. Crit Care Med 2009; 37: S295.Google Scholar
Halperin, J, Luft, BJ, Volkman, DJ, et al. Lyme neuroborreliosis: peripheral nervous system manifestations. Brain 1990; 113: 1207.CrossRefGoogle ScholarPubMed
Hansen-Flaschen, J. Neuromuscular complications of critical illness. Pulmonary Perspectives 1997; 14(4): 1.Google Scholar
Harrison, MS. ‘Epidemic vertigo’ – ‘vestibular neuronitis’: a clinical study. Brain 1962; 85: 613.Google Scholar
Hillbom, M, Wennberg, A. Prognosis of alcoholic peripheral neuropathy. J Neurol Neurosurg Psychiatry 1984; 47: 699.Google Scholar
Hund, EF, Fogel, W, Krieger, D, et al. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 1996; 24: 1328.Google Scholar
Latronico, N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intens Care Med 2003; 29: 1411.Google Scholar
Latronico, N, Fenzi, F, Recupero, D, et al. Critical illness myopathy and neuropathy. Lancet 1996; 347: 1579.Google Scholar
Leijten, FSS, De Weerd, AW, Poortvliet, DCJ, et al. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intens Care Med 1996; 22: 856.Google Scholar
Maramattom, BV, Wijdicks, EFM. Acute neuromuscular weakness in the intensive care unit. Crit Care Med 2006; 34: 2835.Google Scholar
Nates, JL, Cooper, DJ, Day, B, et al. Acute weakness syndromes in critically ill patients – a reappraisal. Anaesth Intens Care 1997; 25: 502.Google Scholar
Pestronk, A. Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991; 14: 927.Google Scholar
Polkey, MI, Moxham, J. Clinical aspects of respiratory muscle dysfunction in the critically ill. Chest 2001; 119: 926.CrossRefGoogle ScholarPubMed
Segredo, V, Caldwell, JE, Matthay, MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327: 524.Google Scholar
Spies, JM. Cranial and peripheral neuropathies. Med J Aust 2001; 174: 598.CrossRefGoogle ScholarPubMed
Sweet, WH. The treatment of trigeminal neuralgia (tic douloureux). N Engl J Med 1986; 315: 174.Google Scholar
Tonner, DR, Schlechte, JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am 1993; 77: 251.Google Scholar
van Mook, WNKA, Hulsewe-Evers, RPMG. Critical illness polyneuropathy. Curr Opin Crit Care 2002; 8: 302.Google Scholar
Walsh, TS. Pharmacologic therapies for ICU-acquired weakness: a long road ahead. Crit Care Med 2016; 44: 1245.Google Scholar
Williams, AC, Sturman, S, Kelsey, S, et al. The neuropathy of the critically ill. BMJ 1986; 293: 790.Google Scholar
Windebank, AJ, Blexrud, MD, Dyck, PJ, et al. The syndrome of acute sensory neuropathy: clinical features and electrophysiologic and pathologic changes. Neurology 1990; 40: 584.Google Scholar
Zochodne, DW, Bolton, CF, Wells, GA, et al. Critical illness polyneuropathy: A complication of sepsis and multiple organ failure. Brain 1987; 110: 819.Google Scholar
Bibliography
Bain, BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol 1996; 49: 664.Google Scholar
Cowburn, AS, Condliffe, AM, Farahi, N, et al. Advances in neutrophil biology: clinical implications. Chest 2008; 134: 606.Google Scholar
Jones, RN. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia. Clin Infect Dis 1999; 29: 495.Google Scholar
Klastersky, JA, Meert, A-P. Understanding the risk for infection in patients with neutropenia. Intens Care Med 2016; 42: 268.Google Scholar
Lingaratnam, S, Slavin, MA, Koczwara, B, et al. Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Intern Med J 2011; 41 (suppl. 1): 75.Google Scholar
Palmblad, JE, von dem Borne, AE. Idiopathic, immune, infectious, and idiosyncratic neutropenias. Semin Hematol 2002; 39: 113.Google Scholar
Schram, AM, Berliner, N. Nonmalignant disorders of leukocytes. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
van der Klauw, MM, Wilson, JH, Stricker, BH. Drug-associated agranulocytosis. Am J Haematol 1998; 57: 206.Google Scholar
Bibliography
Myles, PS, Leslie, K, Silbert, B, et al. A review of the risks and benefits of nitrous oxide in current anaesthetic practice. Anaesth Intens Care 2004; 32: 165.Google Scholar
Bibliography
Brown-Elliott, BA, Brown, JM, Conville, PS, et al. Clinical and laboratory features of Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19: 259.Google Scholar
Lederman, ER, Crum, NF. A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore) 2004; 83: 300.Google Scholar
Threlkeld, SC, Hooper, DC. Update on management of patients with Nocardia infection. Curr Clin Top Infect Dis 1997; 17: 1.Google Scholar
Bibliography
Donnelly, KL, Smith, CI, Schwarzenberg, SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343.Google Scholar
Huang, TD, Behary, J, Zekry, A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J 2020; 50: 1038.Google Scholar
Matteoni, CA, Younossi, ZM, Gramlich, T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 1999; 116: 1413.Google Scholar
Younossi, Z, Anstee, QM, Marietti, M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018; 15: 11.Google Scholar
Younossi, ZM, Koenig, AB, Abdelatif, D, et al. Global epidemiology of non-alcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73.Google Scholar
Bibliography
Sheth, SG, Gordon, FD, Chopra, S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137.CrossRefGoogle ScholarPubMed
Younossi, Z, Anstee, QM, Marietti, M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018; 15: 11.Google Scholar
Bibliography
Dolin, R, Treanor, JJ, Madore, HP. Novel agents of viral enteritis in humans. J Infect Dis 1987; 155: 365.Google Scholar
Frankhauser, RL, Monroe, SS, Noel, JS, et al. Epidemiologic and molecular trends of Norwalk-like viruses associated with outbreaks of gastroenteritis in the United States. J Infect Dis 2002; 186: 1.Google Scholar